Review



af1924 foxa2 rabbit  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    R&D Systems af1924 foxa2 rabbit
    Af1924 Foxa2 Rabbit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 604 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/af1924 foxa2 rabbit/product/R&D Systems
    Average 96 stars, based on 604 article reviews
    af1924 foxa2 rabbit - by Bioz Stars, 2026-06
    96/100 stars

    Images



    Similar Products

    94
    Miltenyi Biotec sox17
    Sox17, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sox17/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    sox17 - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    96
    R&D Systems af1924 foxa2 rabbit
    Af1924 Foxa2 Rabbit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/af1924 foxa2 rabbit/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    af1924 foxa2 rabbit - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    96
    R&D Systems sox17 goat
    Sox17 Goat, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sox17 goat/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    sox17 goat - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    96
    R&D Systems sox17
    Sox17, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sox17/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    sox17 - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    86
    Charles River Laboratories sox17 p pro133ala mice
    Clinical course of a patient with <t>SOX17</t> <t>p.Pro133Ala</t> variant and its structural changes. ( A ) The clinical time-course of the patient with severe pulmonary arterial hypertension who has the heterozygous SOX17 c.397 C > G (p.Pro133Ala) variant. The patient died shortly after right heart catheterization at X + 14 months. The blue line shows mean pulmonary arterial pressure (mPAP), the orange line shows pulmonary vascular resistance (PVR), and the black line shows serum levels of B-type natriuretic peptide (BNP). The medications are shown above the graph. ( B ) The 3D structure of HMG box of SOX17 for wild type (red) and Pro133Ala mutation (yellow). A change of p.Pro133Ala position is demonstrated as the black structure. The double-strand DNA structure is indicated in light blue. PDE5, phosphodiesterase type 5; p.o., per os.
    Sox17 P Pro133ala Mice, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sox17 p pro133ala mice/product/Charles River Laboratories
    Average 86 stars, based on 1 article reviews
    sox17 p pro133ala mice - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    95
    Thermo Fisher gene exp sox17 hs00751752 s1
    Clinical course of a patient with <t>SOX17</t> <t>p.Pro133Ala</t> variant and its structural changes. ( A ) The clinical time-course of the patient with severe pulmonary arterial hypertension who has the heterozygous SOX17 c.397 C > G (p.Pro133Ala) variant. The patient died shortly after right heart catheterization at X + 14 months. The blue line shows mean pulmonary arterial pressure (mPAP), the orange line shows pulmonary vascular resistance (PVR), and the black line shows serum levels of B-type natriuretic peptide (BNP). The medications are shown above the graph. ( B ) The 3D structure of HMG box of SOX17 for wild type (red) and Pro133Ala mutation (yellow). A change of p.Pro133Ala position is demonstrated as the black structure. The double-strand DNA structure is indicated in light blue. PDE5, phosphodiesterase type 5; p.o., per os.
    Gene Exp Sox17 Hs00751752 S1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gene exp sox17 hs00751752 s1/product/Thermo Fisher
    Average 95 stars, based on 1 article reviews
    gene exp sox17 hs00751752 s1 - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    96
    R&D Systems shrnas antibodies against sox17
    Clinical course of a patient with <t>SOX17</t> <t>p.Pro133Ala</t> variant and its structural changes. ( A ) The clinical time-course of the patient with severe pulmonary arterial hypertension who has the heterozygous SOX17 c.397 C > G (p.Pro133Ala) variant. The patient died shortly after right heart catheterization at X + 14 months. The blue line shows mean pulmonary arterial pressure (mPAP), the orange line shows pulmonary vascular resistance (PVR), and the black line shows serum levels of B-type natriuretic peptide (BNP). The medications are shown above the graph. ( B ) The 3D structure of HMG box of SOX17 for wild type (red) and Pro133Ala mutation (yellow). A change of p.Pro133Ala position is demonstrated as the black structure. The double-strand DNA structure is indicated in light blue. PDE5, phosphodiesterase type 5; p.o., per os.
    Shrnas Antibodies Against Sox17, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/shrnas antibodies against sox17/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    shrnas antibodies against sox17 - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    93
    R&D Systems mouse anti sox17
    Clinical course of a patient with <t>SOX17</t> <t>p.Pro133Ala</t> variant and its structural changes. ( A ) The clinical time-course of the patient with severe pulmonary arterial hypertension who has the heterozygous SOX17 c.397 C > G (p.Pro133Ala) variant. The patient died shortly after right heart catheterization at X + 14 months. The blue line shows mean pulmonary arterial pressure (mPAP), the orange line shows pulmonary vascular resistance (PVR), and the black line shows serum levels of B-type natriuretic peptide (BNP). The medications are shown above the graph. ( B ) The 3D structure of HMG box of SOX17 for wild type (red) and Pro133Ala mutation (yellow). A change of p.Pro133Ala position is demonstrated as the black structure. The double-strand DNA structure is indicated in light blue. PDE5, phosphodiesterase type 5; p.o., per os.
    Mouse Anti Sox17, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti sox17/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    mouse anti sox17 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec anti sox17 conjugated to apc
    Clinical course of a patient with <t>SOX17</t> <t>p.Pro133Ala</t> variant and its structural changes. ( A ) The clinical time-course of the patient with severe pulmonary arterial hypertension who has the heterozygous SOX17 c.397 C > G (p.Pro133Ala) variant. The patient died shortly after right heart catheterization at X + 14 months. The blue line shows mean pulmonary arterial pressure (mPAP), the orange line shows pulmonary vascular resistance (PVR), and the black line shows serum levels of B-type natriuretic peptide (BNP). The medications are shown above the graph. ( B ) The 3D structure of HMG box of SOX17 for wild type (red) and Pro133Ala mutation (yellow). A change of p.Pro133Ala position is demonstrated as the black structure. The double-strand DNA structure is indicated in light blue. PDE5, phosphodiesterase type 5; p.o., per os.
    Anti Sox17 Conjugated To Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti sox17 conjugated to apc/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    anti sox17 conjugated to apc - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    Image Search Results


    Clinical course of a patient with SOX17 p.Pro133Ala variant and its structural changes. ( A ) The clinical time-course of the patient with severe pulmonary arterial hypertension who has the heterozygous SOX17 c.397 C > G (p.Pro133Ala) variant. The patient died shortly after right heart catheterization at X + 14 months. The blue line shows mean pulmonary arterial pressure (mPAP), the orange line shows pulmonary vascular resistance (PVR), and the black line shows serum levels of B-type natriuretic peptide (BNP). The medications are shown above the graph. ( B ) The 3D structure of HMG box of SOX17 for wild type (red) and Pro133Ala mutation (yellow). A change of p.Pro133Ala position is demonstrated as the black structure. The double-strand DNA structure is indicated in light blue. PDE5, phosphodiesterase type 5; p.o., per os.

    Journal: Scientific Reports

    Article Title: Experimental pulmonary arterial hypertension in mice with a pathogenic SOX17 variant

    doi: 10.1038/s41598-026-46893-0

    Figure Lengend Snippet: Clinical course of a patient with SOX17 p.Pro133Ala variant and its structural changes. ( A ) The clinical time-course of the patient with severe pulmonary arterial hypertension who has the heterozygous SOX17 c.397 C > G (p.Pro133Ala) variant. The patient died shortly after right heart catheterization at X + 14 months. The blue line shows mean pulmonary arterial pressure (mPAP), the orange line shows pulmonary vascular resistance (PVR), and the black line shows serum levels of B-type natriuretic peptide (BNP). The medications are shown above the graph. ( B ) The 3D structure of HMG box of SOX17 for wild type (red) and Pro133Ala mutation (yellow). A change of p.Pro133Ala position is demonstrated as the black structure. The double-strand DNA structure is indicated in light blue. PDE5, phosphodiesterase type 5; p.o., per os.

    Article Snippet: Single-stranded oligodeoxynucleotide was described in supplemental figure A. Sox17 +/p.Pro133Ala mice were generated using electroporation technique done by Charles River Laboratories (Supplemental Figure A).

    Techniques: Variant Assay, Medications, Mutagenesis

    Gene expression is regulated by the Sox17 +/p.Pro133Ala variant. Changes in gene expression in Sox17 +/p.Pro133Ala mice (hetero) compared with wild-type mice were analyzed using RNA-sequencing and displayed as a volcano plot ( A ) and heat map ( B ). ( C ) Changes in gene expression in both groups were assessed using gene ontology analysis.

    Journal: Scientific Reports

    Article Title: Experimental pulmonary arterial hypertension in mice with a pathogenic SOX17 variant

    doi: 10.1038/s41598-026-46893-0

    Figure Lengend Snippet: Gene expression is regulated by the Sox17 +/p.Pro133Ala variant. Changes in gene expression in Sox17 +/p.Pro133Ala mice (hetero) compared with wild-type mice were analyzed using RNA-sequencing and displayed as a volcano plot ( A ) and heat map ( B ). ( C ) Changes in gene expression in both groups were assessed using gene ontology analysis.

    Article Snippet: Single-stranded oligodeoxynucleotide was described in supplemental figure A. Sox17 +/p.Pro133Ala mice were generated using electroporation technique done by Charles River Laboratories (Supplemental Figure A).

    Techniques: Gene Expression, Variant Assay, RNA Sequencing

    Therapeutic intervention of the AhR signaling pathway in Sox17 +/p.Pro133Ala mice. ( A ) Relative gene expression of cytochrome p450 1b1 ( Cyp1b1 ). Right ventricle (RV)/body weight (BW) ( B ), Fulton index ( C ), right ventricular systolic pressure (RVSP) ( D ) were measured in wild-type and Sox17 +/p.Pro133Ala mice (hetero) with or without CH-223,191, respectively. ( E ) Images of the pulmonary arteries of mice observed by Elastica van Gieson staining. Scale bars, 50 μm. ( F ) Medial wall thickness (MWT) was also measured. ns = not significant. * p < 0.05.

    Journal: Scientific Reports

    Article Title: Experimental pulmonary arterial hypertension in mice with a pathogenic SOX17 variant

    doi: 10.1038/s41598-026-46893-0

    Figure Lengend Snippet: Therapeutic intervention of the AhR signaling pathway in Sox17 +/p.Pro133Ala mice. ( A ) Relative gene expression of cytochrome p450 1b1 ( Cyp1b1 ). Right ventricle (RV)/body weight (BW) ( B ), Fulton index ( C ), right ventricular systolic pressure (RVSP) ( D ) were measured in wild-type and Sox17 +/p.Pro133Ala mice (hetero) with or without CH-223,191, respectively. ( E ) Images of the pulmonary arteries of mice observed by Elastica van Gieson staining. Scale bars, 50 μm. ( F ) Medial wall thickness (MWT) was also measured. ns = not significant. * p < 0.05.

    Article Snippet: Single-stranded oligodeoxynucleotide was described in supplemental figure A. Sox17 +/p.Pro133Ala mice were generated using electroporation technique done by Charles River Laboratories (Supplemental Figure A).

    Techniques: Gene Expression, Staining

    Gene expressions associated with Sox17 variant and AhR signals. ( A ) The number of genes whose expression was changed by genotype and administration of CH-223,191 in RNA-sequencing using lung tissues. ( B ) The number of genes narrowed down by the criteria described in the method section. Upper panel: genes whose expression is decreased in Sox17 +/p.Pro133Ala mice (hetero) compared with wild-type mice, lower panel: genes whose expression is increased in Sox17 +/p.Pro133Ala mice compared with wild-type mice. Relative gene expressions of Bmpr2 ( C ), Col4a1 ( D ), and Col4a2 ( E ) measured by qPCR. ns = not significant. * p < 0.05. AhR, aryl hydrocarbon receptor; Bmpr2, bone morphogenetic protein receptor type 2; Col4a, collagen, type IV, alpha; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.

    Journal: Scientific Reports

    Article Title: Experimental pulmonary arterial hypertension in mice with a pathogenic SOX17 variant

    doi: 10.1038/s41598-026-46893-0

    Figure Lengend Snippet: Gene expressions associated with Sox17 variant and AhR signals. ( A ) The number of genes whose expression was changed by genotype and administration of CH-223,191 in RNA-sequencing using lung tissues. ( B ) The number of genes narrowed down by the criteria described in the method section. Upper panel: genes whose expression is decreased in Sox17 +/p.Pro133Ala mice (hetero) compared with wild-type mice, lower panel: genes whose expression is increased in Sox17 +/p.Pro133Ala mice compared with wild-type mice. Relative gene expressions of Bmpr2 ( C ), Col4a1 ( D ), and Col4a2 ( E ) measured by qPCR. ns = not significant. * p < 0.05. AhR, aryl hydrocarbon receptor; Bmpr2, bone morphogenetic protein receptor type 2; Col4a, collagen, type IV, alpha; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.

    Article Snippet: Single-stranded oligodeoxynucleotide was described in supplemental figure A. Sox17 +/p.Pro133Ala mice were generated using electroporation technique done by Charles River Laboratories (Supplemental Figure A).

    Techniques: Variant Assay, Expressing, RNA Sequencing

    Graphical abstract. AhR, aryl hydrocarbon receptor; Bmpr2, bone morphogenetic protein receptor type 2; Col4a, collagen, type IV, alpha; Cyp1b1, cytochrome P450 family 1 subfamily B member 1; SOX17, SRY-box transcription factor 17. Created in https://BioRender.com .

    Journal: Scientific Reports

    Article Title: Experimental pulmonary arterial hypertension in mice with a pathogenic SOX17 variant

    doi: 10.1038/s41598-026-46893-0

    Figure Lengend Snippet: Graphical abstract. AhR, aryl hydrocarbon receptor; Bmpr2, bone morphogenetic protein receptor type 2; Col4a, collagen, type IV, alpha; Cyp1b1, cytochrome P450 family 1 subfamily B member 1; SOX17, SRY-box transcription factor 17. Created in https://BioRender.com .

    Article Snippet: Single-stranded oligodeoxynucleotide was described in supplemental figure A. Sox17 +/p.Pro133Ala mice were generated using electroporation technique done by Charles River Laboratories (Supplemental Figure A).

    Techniques: